Leucovorin (Folinic Acid): Clinical Applications and Dosing
Leucovorin is primarily indicated as a rescue agent after high-dose methotrexate therapy, as an antidote for methotrexate overdose, and as a chemotherapy potentiator when combined with 5-fluorouracil in advanced colorectal cancer. 1
Primary Indications
1. Methotrexate Rescue After High-Dose Therapy
Begin leucovorin at 15 mg (approximately 10 mg/m²) every 6 hours for 10 doses, starting exactly 24 hours after the methotrexate infusion begins. 1 This timing is critical—the FDA label emphasizes that leucovorin effectiveness decreases as the time interval from methotrexate administration increases 2.
Dosing adjustments based on methotrexate levels:
- Normal elimination (MTX <0.2 micromolar at 72 hours): Continue standard 15 mg every 6 hours
- Delayed late elimination (MTX >0.2 micromolar at 72 hours): Continue 15 mg every 6 hours until MTX <0.05 micromolar
- Delayed early elimination or renal injury (MTX ≥50 micromolar at 24 hours OR ≥5 micromolar at 48 hours): Escalate to 150 mg IV every 3 hours until MTX <1 micromolar, then 15 mg every 3 hours until <0.05 micromolar 1
Continue hydration and urinary alkalinization (pH ≥7.0) throughout rescue 1.
2. Methotrexate Overdose (Emergency Antidote)
For suspected methotrexate overdose, administer folinic acid at 10 mg/m² immediately, then repeat every 6 hours. 2 The British guidelines specify up to 100 mg/m² IV initially if MTX level is unknown, with subsequent doses every 6 hours until MTX levels fall below 0.05 µmol/L 3.
Critical actions:
- If ≥1 mg/kg MTX ingested within 1 hour: give activated charcoal first
- Admit to hospital and measure serum MTX levels at least 4 hours post-ingestion
- Maintain aggressive hydration and consider urine alkalinization with sodium bicarbonate
- Consider filgrastim 5 mcg/kg/day subcutaneously for bone marrow suppression 3
Time is critical—leucovorin has doubtful efficacy if initiated >24 hours after the last methotrexate dose. 3
3. Advanced Colorectal Cancer (with 5-Fluorouracil)
Two FDA-approved regimens exist 1:
High-dose regimen:
- Leucovorin 200 mg/m² IV over minimum 3 minutes
- Followed by 5-FU 370 mg/m² IV
- Daily for 5 days, repeated every 4 weeks
Low-dose regimen:
- Leucovorin 20 mg/m² IV
- Followed by 5-FU 425 mg/m² IV
- Daily for 5 days, repeated every 4 weeks
Never mix leucovorin and 5-FU in the same infusion—a precipitate will form. 1 Administer separately.
Clinical data show equivalent therapeutic benefit between high-dose and low-dose leucovorin regimens 4, making the low-dose option more cost-effective without sacrificing efficacy.
Secondary/Off-Label Uses
Methotrexate Toxicity Prevention in Dermatology
For patients on low-dose weekly methotrexate (psoriasis, rheumatoid arthritis), folic acid 1-5 mg daily (NOT on methotrexate day) is preferred over leucovorin for routine supplementation 2. However, when worrisome hematologic toxicity develops (significant drops in WBC, platelets, or RBC), switch to folinic acid 10 mg/m² immediately 2.
A 1993 randomized controlled trial demonstrated that leucovorin 2.5-5 mg given 24 hours after weekly methotrexate reduced side effects by nearly 50% without compromising efficacy 5.
Autism Spectrum Disorder (Investigational)
Recent research shows potential benefit, particularly in children with folate receptor autoantibodies. A 2024 RCT found that folinic acid 2 mg/kg/day (maximum 50 mg/day) for 24 weeks significantly improved CARS scores compared to placebo 6. A 2025 study confirmed safety and efficacy, with more pronounced benefits in children with high-titer folate receptor autoantibodies 7.
However, the American Academy of Pediatrics does not currently recommend leucovorin for ASD 8, so this remains investigational despite promising data.
Contraindications and Precautions
Absolute contraindication: Never administer leucovorin intrathecally—this is explicitly prohibited in FDA labeling 1.
Critical drug interaction: Do not use leucovorin to counteract intentional folic acid antagonism in conditions where folate antagonism is therapeutic (e.g., pernicious anemia being treated with vitamin B12).
Monitoring requirements during high-dose MTX rescue:
- Serum creatinine and methotrexate levels at least daily
- Watch for 100% increase in creatinine at 24 hours post-MTX (signals acute renal injury requiring dose escalation)
- Continue monitoring until MTX <0.05 micromolar 1
Common Pitfalls
- Timing errors: Starting leucovorin too early (<24 hours) or too late (>24 hours) after high-dose methotrexate reduces efficacy
- Confusing folic acid with folinic acid: These are different compounds—folinic acid (leucovorin) bypasses the metabolic block created by methotrexate, while folic acid does not
- Mixing with 5-FU: Always administer separately to prevent precipitation 1
- Inadequate dose escalation: Failing to recognize delayed methotrexate elimination and not escalating to 150 mg every 3 hours when indicated 1
- Tablet strength confusion: Leucovorin comes in 10 mg and 25 mg tablets that look similar—prescribe only one strength and write doses in full uppercase to avoid decimal point errors 3